ENSC
Price:
$8.26
Market Cap:
$10.78M
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP prodrug candidate of oxycodone, which is in Phase II clinical trial for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat that is in Phase I clinical trial for overdose protection agains...[Read more]
Industry
Biotechnology
IPO Date
2018-03-14
Stock Exchange
NASDAQ
Ticker
ENSC
According to Ensysce Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.01M. This represents a change of -85.73% compared to the average of 49.14M of the last 4 quarters.
The mean historical Enterprise Value of Ensysce Biosciences, Inc. over the last ten years is 2.21B. The current 7.01M Enterprise Value has changed -68.20% with respect to the historical average. Over the past ten years (40 quarters), ENSC's Enterprise Value was at its highest in in the March 2020 quarter at 250.39B. The Enterprise Value was at its lowest in in the September 2024 quarter at 31.84M.
Average
2.21B
Median
2.95B
Minimum
25.55M
Maximum
3.69B
Discovering the peaks and valleys of Ensysce Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 39.84%
Maximum Annual Enterprise Value = 3.69B
Minimum Annual Increase = -98.20%
Minimum Annual Enterprise Value = 25.55M
Year | Enterprise Value | Change |
---|---|---|
2023 | 35.73M | 39.84% |
2022 | 25.55M | -98.20% |
2021 | 1.42B | -51.72% |
2020 | 2.95B | -20.09% |
2019 | 3.69B | 0.27% |
2018 | 3.68B | 0.82% |
The current Enterprise Value of Ensysce Biosciences, Inc. (ENSC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
494.45M
5-year avg
1.62B
10-year avg
2.21B
Ensysce Biosciences, Inc.’s Enterprise Value is greater than Zura Bio Limited (-32822399.00), greater than Phio Pharmaceuticals Corp. (-3036859.00), greater than Sonnet BioTherapeutics Holdings, Inc. (4.31M), greater than 180 Life Sciences Corp. (3.98M), less than Cardio Diagnostics Holdings, Inc. (40.39M), greater than Virax Biolabs Group Limited (4.97M), less than Blue Water Vaccines, Inc. (12.55M), greater than Revelation Biosciences, Inc. (-4014046.00), greater than Hillstream BioPharma, Inc. (1.48M), greater than Kiora Pharmaceuticals, Inc. (4.31M), greater than Quoin Pharmaceuticals, Ltd. (-480796.00), greater than Allarity Therapeutics, Inc. (-12515070.00), less than Kiromic BioPharma, Inc. (13.21M), less than Biodexa Pharmaceuticals Plc (703.41M), greater than PaxMedica, Inc. Common Stock (394.63K),
Company | Enterprise Value | Market cap |
---|---|---|
-32822399.00 | $155.40M | |
-3036859.00 | $2.35M | |
4.31M | $4.33M | |
3.98M | $3.70M | |
40.39M | $41.65M | |
4.97M | $8.34M | |
12.55M | $3.41M | |
-4014046.00 | $2.53M | |
1.48M | $4.17M | |
4.31M | $9.87M | |
-480796.00 | $2.64M | |
-12515070.00 | $4.61M | |
13.21M | $1.42M | |
703.41M | $887.52M | |
394.63K | $719.12K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ensysce Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ensysce Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Ensysce Biosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Ensysce Biosciences, Inc. (ENSC)?
What is the 3-year average Enterprise Value for Ensysce Biosciences, Inc. (ENSC)?
What is the 5-year average Enterprise Value for Ensysce Biosciences, Inc. (ENSC)?
How does the current Enterprise Value for Ensysce Biosciences, Inc. (ENSC) compare to its historical average?